AstraZeneca Chief Executive Pascal Soriot
Media playback is unsupported on your device

AstraZeneca boss: Pfizer bid 'could delay drug development'

The chief executive of AstraZeneca has warned that new drug development could be hit if it was taken over by Pfizer.

Pascal Soriot told BBC News that a takeover would create huge disruption.

  • 13 May 2014
Go to next video: AstraZeneca Pfizer bid explained